Bharat Biotech follows SII, reduces Covaxin price to Rs 400 for states

Earlier, the Bharat Biotech vaccine was priced at Rs 600 a dose

Bharat Biotech on Thursday reduced the price of Covaxin, an indigenously developed Covid-19 vaccine, by 33 per cent for state governments to Rs 400 a dose. Earlier, it was priced at Rs 600 a dose. The prices for the international market ($15-20 a dose) and private hospitals (Rs 1,200 a dose) remain the same as previously announced.
 
The move came a day after Serum Institute of India cut the price of its Covishield vaccine to Rs 300 from Rs 400 a dose for states. On Monday, the Centre had asked the two vaccine makers to reduce their prices, following